The Association between Serum Resistin Level and Presence or Severity of Coronary Heart Disease
Article Notes and Dates
International Cardiovascular Research Journal: March 31, 2017,
; e10563.Published Online: March 01, 2017
Article Type: Research Article; Received: July 23, 2016; Revised: October 05, 2016; Accepted: October 22, 2016
To Cite :
R, Rasekhi Kazerouni
M A, Ranjbar Omrani
M. et al. The Association between Serum Resistin Level and Presence or Severity of Coronary Heart Disease,
Int Cardio Res J.
Copyright © 2017, Shiraz University of Medical Sciences. .
Background: Obesity is a well-known principal risk factor for metabolic disorders and cardiovascular diseases. Resistin is one of adipocyte-derived molecules, which plays important roles in inflammation as well as in endocrine and cardiovascular systems. Objectives: The present study aimed to determine the association between serum resistin level and presence/severity of Coronary Heart Disease (CHD). Patients and Methods: This cross-sectional study was conducted on 155 individuals referred for coronary angiography. Information about the patients’ age, gender, and cardiovascular risk factors was recorded. Their weight, height, and waist and hip circumferences were measured, as well. Each coronary angiogram was reported for two scoring methods (number of vessel diseases (usual method) and Gensini scoring system) by one cardiologist who was not aware of the participants’ serum resistin levels. Then, the relationship between serum resistin level and presence/severity of CHD was evaluated. Results: The results revealed no significant associations between the mean serum resistin level and the presence of CHD by both methods of evaluation of the coronary angiograms after adjustment for all conventional risk factors for CHD. In addition, no significant association was detected between serum resistin level and the severity of CHD based on the usual method of reporting the coronary angiograms (number of vessel diseases) (P = 0.332). Yet, serum resistin level was positively correlated to body mass index and waist and hip circumferences and negatively related to height and fasting blood sugar level. Moreover, no linear correlation was found between serum resistin level and Gensini score (P = 0.35). Finally, hip circumference (P = 0.002) and height (P = 0.018) were determined as the predictors of serum resistin level. Conclusions: This cross-sectional study showed no significant associations between serum resistin level and presence/severity of CHD.